New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 16, 2014
09:25 EDTAVTH, AVTH, SSET, SSET, AWK, AWK, NBS, NBS, SNWV, SNWV, ATNM, ATNM, VTEQ, VTEQ, AKER, AKER, CGIX, CGIX, DIRI, DIRIRedChip Companies to hold a virtual conference
Global Online CEO Conference to be held on July 16-17 with webcasted presentations to begin on July 16 at 9:30 am. Webcast Link
News For AVTH;CGIX;AKER;VTEQ;ATNM;SNWV;NBS;AWK;SSET;DIRI From The Last 14 Days
Check below for free stories on AVTH;CGIX;AKER;VTEQ;ATNM;SNWV;NBS;AWK;SSET;DIRI the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
September 11, 2014
07:32 EDTNBSNeoStem licenses patent portfolio from Rockefeller University
Subscribe for More Information
07:28 EDTAWKPR Newswire to hold a virtual conference
Subscribe for More Information
September 10, 2014
07:05 EDTATNMRodman & Renshaw to hold a conference
Subscribe for More Information
September 9, 2014
07:45 EDTAKERAkers Biosciences announces $864K sales contract
Subscribe for More Information
07:12 EDTDIRIEuro Pacific to hold a conference
Subscribe for More Information
September 8, 2014
07:18 EDTNBSRodman & Renshaw to hold a conference
Subscribe for More Information
September 3, 2014
07:02 EDTATNMActinium Pharmaceuticals files orphan drug application for Actimab-A
Subscribe for More Information
September 2, 2014
10:02 EDTAWKOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
08:32 EDTCGIXCancer Genetics IVD for cervical cancer receives CE Mark
Cancer Genetics announced that their proprietary DNA-probe based test for cervical cancer, or FHACT, has received the CE Marking. The CE marking indicates the test's compliance with European Union product safety legislation and allows FHACT to be sold freely within the European Economic Area, or EEA, which includes the 28 member states of the EU as well as the European Free Trade Association. Cancer Genetics' proprietary FHACT test, which can identify irreversible genomic changes associated with progression to cancer, adds predictive value to this screening protocol. In addition to identifying those women most at risk for cervical disease, it can help reduce unnecessary, invasive testing and over-treatment in women who do not show the genomic abnormalities associated with disease progression.
07:23 EDTVTEQVeriTeQ to host business news update conference call
Conference call will be held on September 3 at 10 am.
05:26 EDTAWKAmerican Water downgraded to Market Perform from Outperform at Wells Fargo
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use